patients with acute leukemia: 29 with chronic myeloid leukemia in blast crisis (CML-BC), 14 with acute myeloid leukemia (AML; FAB M1, n = 4; FAB M2, n = 2; FAB M4, n = 8), two Introduction with acute lymphoblastic leukemia (ALL), and two with unclassified acute leukemia. All samples contained Ͼ50% Neoplasia is generally considered to have a multi-step pathoblast cells. We have also studied samples from 19 normal genesis, 1 but a full description of genetic lesions that lead to individuals as controls and three leukemia cell lines (KG1, leukemia is lacking. A large number of proto-oncogenes have KCL22 and K562). been characterized and many have been shown to encode proteins that participate in signal transduction pathways. In general, then, signal transduction components may be con-
RT-PCR for G-CSF-R
sidered as candidates for disruption or alteration in leukemia.
The granulocyte colony-stimulating factor receptor (G-CSFMononuclear cells were isolated by density gradient centrifug-R) transduces signals important for proliferation and matuation. Total cellular RNA was prepared by lysis in guanidine ration or differentiation of myeloid progenitor cells to neutroisothiocyanate and cesium chloride ultracentrifugation as philic granulocytes. [2] [3] [4] [5] The membrane-proximal cytoplasmic described. 12 Ten micrograms of total RNA were used for firstregion of the G-CSF-R is indispensible for growth while the strand cDNA synthesis using random hexamer primers. 13 PCR membrane-distal region is involved in transducing signals for primers were designed from the published sequence of the Gdifferentiation and/or maturation. [6] [7] [8] Premature stop codons in CSF-R cDNA (clone pHQ3, 14 ) to amplify a 608 bp fragment the membrane-distal region that lead to truncation of the Gencompassing the sequence encoding the entire cytoplasmic CSF-R have been described in several patients with severe domain of the protein. Thirty-two cycles (each 97°C for 20 s, congenital neutropenia (SCN) who subsequently developed 66°C for 50 s, 73°C for 60 s) of polymerase chain reaction acute myeloid leukemia (AML). 9, 10 These results suggest that (PCR) amplification were performed in a total volume of 25l. mutations in the cytoplasmic domain of the G-CSF-R may play
The forward primer was, 5′-GTGGAtCcGCCTGGCTCTa role in the development of other myeloid leukemias. How-GTTGCA-3′, identical to nucleotide position 2097-2121 of the pHQ3 cDNA except for two nucleotide mismatches introduced to insert a BamHI site for cloning (indicated in lower
Mutational analysis
were found in a single individual with AML (patient KG; Figure 1 ). Sequencing of the PCR product from patient KG revealed two point mutations. The first mutation occurred at Two microliters of PCR product were labelled by re-amplification for three cycles, including 2 Ci [␣-32 P] dCTP per reacnucleotide 2390 and was a C-to-T transition, changing the CAA codon at position 718 (Gln 718) to a TAA stop codon tion and lowering the cold dCTP final concentration to 3 M. Labelled fragments were digested with either PvuII or DdeI, (Figure 2 ). This mutation is predicted to result in a protein product with a 96 amino acid C-terminal truncation. The second resulting in three small fragments of 176 bp, 215 bp and 218 bp for DdeI, and 123 bp, 210 bp and 276 bp for PvuII.
mutation was further downstream at nucleotide position 2591 and was a G-to-A transition. This change predicts a substiDigests were diluted 10-fold in 0.1% SDS, 10 mM EDTA and denatured for single-strand conformation polymorphism tution of the normal glutamic acid at position 785 (Glu 785) for a lysine ( Figure 2 ). (SSCP) analysis. 15 Samples were loaded on to 8% non-denaturing polyacrylamide gels with or without 8% glycerol and
The presence of both mutations in patient KG was confirmed by restriction enzyme digestion in independent RT-PCR electrophoresed at room temperature or 4°C, respectively.
products. XcmI cuts the 608 bp normal PCR product to yield two fragments of 292 bp and 316 bp, but this site is eliminated by the Gln 718 → stop mutation. As expected, the 608 bp
Sequence analysis
band was present for patient KG even after exhaustive digestion but the 292 and 316 bp bands were also visible, indicat-PCR products were digested with BamHI, cloned into M13mp19 12 and sequenced (Sequenase Version 2.0 kit; USB, ing that the mutation was heterozygous (Figure 3a) . The Glu 785 → Lys mutation disrupts a BslI site; this enzyme cuts the Cleveland, OH, USA).
normal PCR product into fragments of 128, 124, 104, 87, 55, 48, 41 and 21 bp. If the mutation is present, the 87 bp and 41 bp bands are uncut to give a novel 135 bp fragment. As
Clinical details of patient KG
shown in Figure 3b , the 135 bp band is indeed present for patient KG. In addition, the almost complete loss of the 87 bp A 63-year-old Caucasian woman presented in October 1993 with herpes zoster ophthalmicus. There was no history of an band for this patient suggests that the mutation is homozygous. increased susceptibility to infection. The peripheral blood white blood cell count (WBC) showed severe neutropenia: total leukocytes were 1700 × 10 6 /l with 14% polymorphonucleocytes, 71% lymphocytes, 2% eosinophils, 13% monoDiscussion cytes, platelets 185 000 × 10 6 /l and hemoglobin 10.6 g/dl. A routine examination 14 months previously, had revealed norWe have screened 47 patients with acute leukemia, three myeloid leukemia cell lines and 19 controls for mutations in mal peripheral blood parameters. In December 1993 the WBC was 6300 × 10 6 /l with 52% blasts, 22% polymorphonucleothe cytoplasmic region of the G-CSF-R. Our analysis was restricted to this region for two reasons: (1) because functional cytes and 26% lymphocytes, a platelet count of 250 000 × 10 6 /l and hemoglobin of 10.1 g/dl. The mean coranalysis has demonstrated that it specifically controls differentiation/maturation signalling; and (2) because puscular volume (MCV) of erythrocytes was 105.6 fl, the activity of lactate dehydrogenase was 244 U/l. The spleen was mutations in this domain have been described in some not palpable, the diameter of the liver was 12 cm. A bone marrow aspirate showed moderate hypercellularity with a trilineage dysplasia, bizzare nuclear abnormalities of all myeloid cells, consisting of exaggerated chromatin clumping, mimicking nuclear fragmentation and a loss of segmentation. About 60% of bone marrow cells were immature blasts without maturation. On immunocytochemical analysis, the blasts were 100% positive for CD34, HLA-Ia and elastase, and negative for TdT, CD3, CD7, CD11c, CD14, CD19 and CD22. About 20% of blasts were positive for CD15 and CD33. A diagnosis of secondary acute myeloid leukemia (FAB type M1) evolving from myelodysplasia, with abnormal chromatin clumping syndrome 16 was made. Cytogenetic studies of bone marrow and peripheral blood specimens showed a complex aberrant karyotype: 42−43,XX,del(1)(q42), −5, del(7)(q21), add(9)(p22), −12, −16, −17, add(17)(q25), del(18)(q21), −20, +1−2 mar. The patient failed to enter remission after two cycles of standard intensive chemotherapy and died 7 months after presentation. tional analysis of mutant receptors has demonstrated that they retain the ability to generate a proliferative signal on binding of G-CSF, but are defective in maturation induction. Granulocytic maturation is blocked even in the presence of wild-type receptors, indicating a dominant negative mode of action, presumably by the formation of inactive heterodimers. 8, 10, 17 Furthermore, it is notable that many of the leukemia cases with G-CSF-R mutations, including the case described here, had partial or complete loss of chromosome 7. It is possible that inactivation of a chromosome 7 tumor suppressor gene co- and had no history of susceptibility to infection, it is highly likely that the Gln 718 → stop mutation was acquired. This is the first case of leukemia without congenital neutropenia to patients with SCN who subsequently developed AML. We be described with a dominant negative mutation within the found two point mutations in a single patient with AML-M1 coding sequence of the G-CSF-R. who showed abnormal chromatin clumping. The homozygous Although there was no evidence of consanguinity, the mutation was detected as band shifts by SSCP in all conditions second change in patient KG (Glu 785 → Lys) could be a rare tested. In contrast, the heterozygous mutation was only apparpolymorphism. However, it is a potentially drastic change ent when the amplified product was digested with DdeI and (acid residue to basic residue) that occurs within a block of run on glycerol-containing polyacrylamide gels at room temnine amino acids which are conserved between the human perature. These mutations are predicted to substitute the norand mouse receptors. 18 Furthermore, the presence of faint normal Glu 785 for a lysine and produce a stop codon which mally migrating SSCP bands ( Figure 1 ) and a 87 bp normal would truncate the cytoplasmic tail of the receptor at Gln 718 band after BslI digestion ( Figure 3b , track 2) suggest that the ( Figure 2) . No mutations were found in any other patients, cell mutation was acquired, at least on one allele. lines or normal controls.
In conclusion, we have found that mutations in the All of the naturally occurring G-CSF-R mutations reported cytoplasmic domain of the G-CSF-R are infrequent in acute to date lead to truncation of the normal carboxy terminus of leukemia and blast crisis of chronic myeloid leukemia but the receptor, either by frameshift mutation, splice site mutation or introduction of a premature stop codon. Funcmay contribute to malignant transformation in some cases. Veerman AJP, Touw IP, Lö wenberg B. Identification of a nonsense
